WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Stock Ownership - Who owns Lenz Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lenz Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Shawn OlssonChief Commercial Officer2025-11-175,788$26.37
$152.61kSell
Shawn OlssonChief Commercial Officer2025-11-1710,000$2.08
$20.80kBuy
Shawn OlssonChief Commercial Officer2025-11-174,212$25.74
$108.41kSell
Daniel R. ChevallardChief Financial Officer2025-11-072,178$22.76
$49.56kBuy
James W. McCollumDirector2025-11-0710,500$22.79
$239.27kBuy
Daniel R. ChevallardChief Financial Officer2025-11-0720$22.71
$454.20Buy
Versant Venture Capital VI LP10% Owner2025-09-30123$47.01
$5.78kSell
Versant Venture Capital VI LP10% Owner2025-09-3049,701$45.36
$2.25MSell
Versant Venture Capital VI LP10% Owner2025-09-3034,405$45.36
$1.56MSell
Versant Venture Capital VI LP10% Owner2025-09-3083,066$46.41
$3.85MSell

1 of 5

LENZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LENZ insiders and whales buy or sell their stock.

LENZ Shareholders

What type of owners hold Lenz Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC27.29%8,538,446$156.17MInsider
Samsara Biocapital LP27.28%8,534,820$156.10MInsider
Ra Capital Management LP13.36%4,178,823$76.43MInstitution
Alpha Wave Global LP11.54%3,612,211$66.07MInstitution
Alpha Wave Ventures GP Ltd11.54%3,612,211$66.07MInsider
Versant Venture Management LLC8.49%2,656,888$48.59MInstitution
Versant Venture Capital VI LP6.05%1,892,761$34.62MInsider
Davis Jerel5.46%1,707,719$31.23MInsider
Versant Venture Capital VII LP5.11%1,598,789$29.24MInsider
Blackrock Inc4.71%1,473,104$26.94MInstitution

1 of 3

LENZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LENZ49.80%50.20%Net SellingNet Buying
IVVD61.79%38.21%Net SellingNet Buying
KROS79.60%20.40%Net SellingNet Selling
SLS23.11%6.55%Net SellingNet Selling
DNA9.27%90.73%Net SellingNet Selling
View Top Biotech Stocks

Lenz Therapeutics Stock Ownership FAQ

Who owns Lenz Therapeutics?

Lenz Therapeutics (NASDAQ: LENZ) is owned by 93.13% institutional shareholders, 93.89% Lenz Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Lenz Therapeutics shareholder, owning 8.54M shares representing 27.29% of the company. Ecor1 Capital LLC's Lenz Therapeutics shares are currently valued at $156.17M.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.